title: Choroidal infarction following photodynamic therapy with verteporfin.
authors.affiliation: Vitreous-Retina-Macula Consultants of New York, 519 E 72nd Street, Ste. 203, New York, NY 10021, USA. vrmny@aol.com
authors.forename: Christina M
authors.initials: CM
authors.lastname: Klais
authors.forename: Michael D
authors.initials: MD
authors.lastname: Ober
authors.forename: K Bailey
authors.initials: KB
authors.lastname: Freund
authors.forename: Leonard H
authors.initials: LH
authors.lastname: Ginsburg
authors.forename: Alan
authors.initials: A
authors.lastname: Luckie
authors.forename: Martine
authors.initials: M
authors.lastname: Mauget-Faÿsse
authors.forename: Gabriel
authors.initials: G
authors.lastname: Coscas
authors.forename: Nicole E
authors.initials: NE
authors.lastname: Gross
authors.forename: Lawrence A
authors.initials: LA
authors.lastname: Yannuzzi
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D002829:Choroid / Q000098:blood supply*; D020256:Choroidal Neovascularization / Q000188:drug therapy / Q000209:etiology; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D007238:Infarction / Q000139:chemically induced*; D008268:Macular Degeneration / Q000150:complications / Q000188:drug therapy; D008297:Male; D010778:Photochemotherapy / Q000009:adverse effects*; D017319:Photosensitizing Agents / Q000009:adverse effects*; D011166:Porphyrins / Q000009:adverse effects*; D000077362:Verteporfin; D014792:Visual Acuity
chemical_list: D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin